Trifecta Capital Advisors LLC Acquires 330 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

by · The Cerbat Gem

Trifecta Capital Advisors LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,859 shares of the medical equipment provider’s stock after purchasing an additional 330 shares during the period. Trifecta Capital Advisors LLC’s holdings in Intuitive Surgical were worth $5,335,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Mirador Capital Partners LP increased its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares in the last quarter. Advisors Asset Management Inc. raised its holdings in Intuitive Surgical by 18.1% during the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after acquiring an additional 1,129 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares in the last quarter. Brookstone Capital Management lifted its position in shares of Intuitive Surgical by 22.4% in the second quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after acquiring an additional 2,289 shares in the last quarter. Finally, M&G Plc boosted its stake in shares of Intuitive Surgical by 53.5% in the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock worth $2,256,000 after acquiring an additional 1,766 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 0.6 %

ISRG opened at $473.73 on Friday. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $496.48. The business’s fifty day simple moving average is $482.69 and its 200-day simple moving average is $436.91. The company has a market capitalization of $168.03 billion, a price-to-earnings ratio of 85.51, a PEG ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the previous year, the company posted $1.18 earnings per share. The firm’s revenue was up 14.5% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 53,120 shares of company stock worth $25,528,753 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Leerink Partners boosted their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday. Truist Financial boosted their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $515.00 to $525.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Robert W. Baird boosted their price target on shares of Intuitive Surgical from $503.00 to $565.00 in a research note on Thursday. Finally, Mizuho increased their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $484.15.

Check Out Our Latest Research Report on ISRG

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading